NeurogesX (NGSX) Tops Q4 EPS by 7c; Announces Restructuring, Cutting 43 Jobs; Received CRL, FDA Seeking Added Data from Qutenza Trials

Go back to NeurogesX (NGSX) Tops Q4 EPS by 7c; Announces Restructuring, Cutting 43 Jobs; Received CRL, FDA Seeking Added Data from Qutenza Trials
NeurogesX, Inc. (AMEX: NGSX) Delayed: 0.01 --0 (-0%)
Previous Close $0.01    52 Week High $0.01 
Open $1411.93    52 Week Low $0.00 
Day High $0.01    P/E N/A 
Day Low $0.01    EPS $-0.89 
Volume 6,294